BIOMAT Database Logo BIOMAT Database Logo

[The secretion of glucagon and insulin in patients with anti-pancreatic-islet antibodies (ICA +) (proceedings)]. 1976

A Tiengo, and G Del Prete, and R Nosadini, and C Betterle, and G Bersani, and D Fedele

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D048909 Diabetes Complications Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE. Complications of Diabetes Mellitus,Diabetes-Related Complications,Diabetic Complications,Diabetes Complication,Diabetes Mellitus Complication,Diabetes Mellitus Complications,Diabetes Related Complications,Diabetes-Related Complication,Diabetic Complication

Related Publications

A Tiengo, and G Del Prete, and R Nosadini, and C Betterle, and G Bersani, and D Fedele
Glucagon-insulin interactions in patients with insulin-producing pancreatic islet lesions.
February 1979, The Journal of clinical endocrinology and metabolism,
A Tiengo, and G Del Prete, and R Nosadini, and C Betterle, and G Bersani, and D Fedele
Evaluating GIP and glucagon as key regulators of insulin secretion in the pancreatic islet.
May 2024, American journal of physiology. Endocrinology and metabolism,
A Tiengo, and G Del Prete, and R Nosadini, and C Betterle, and G Bersani, and D Fedele
Pancreatic insulin and glucagon content and secretion after infection of mice with EMC virus [proceedings].
January 1977, Biochemical Society transactions,
A Tiengo, and G Del Prete, and R Nosadini, and C Betterle, and G Bersani, and D Fedele
Discovery of ciliary G protein-coupled receptors regulating pancreatic islet insulin and glucagon secretion.
September 2021, Genes & development,
A Tiengo, and G Del Prete, and R Nosadini, and C Betterle, and G Bersani, and D Fedele
[Anti-insulin, proinsulin, pancreatic polypeptide, glucagon and somatostatin antibodies in patients with insulin-dependent diabetes mellitus treated with conventional insulin preparations].
January 1987, Endokrynologia Polska,
A Tiengo, and G Del Prete, and R Nosadini, and C Betterle, and G Bersani, and D Fedele
Regulation of pancreatic insulin and glucagon secretion.
January 1976, Annual review of physiology,
A Tiengo, and G Del Prete, and R Nosadini, and C Betterle, and G Bersani, and D Fedele
[Proceedings: Effects of injection of acetylcholine into the pancreatic artery on glucagon and insulin secretion].
February 1974, Nihon Naibunpi Gakkai zasshi,
A Tiengo, and G Del Prete, and R Nosadini, and C Betterle, and G Bersani, and D Fedele
[Proceedings: Insulin secretion stimulation test by glucagon].
February 1974, Nihon Naibunpi Gakkai zasshi,
A Tiengo, and G Del Prete, and R Nosadini, and C Betterle, and G Bersani, and D Fedele
Insulin Secretion Depends on Intra-islet Glucagon Signaling.
October 2018, Cell reports,
A Tiengo, and G Del Prete, and R Nosadini, and C Betterle, and G Bersani, and D Fedele
Glucagon inhibition of secretion stimulated pancreatic secretion in health and disease [proceedings].
January 1975, Revista de gastroenterologia de Mexico,
Copied contents to your clipboard!